Needham & Company Reiterates a 'Buy' on Regeneron Pharma (REGN); Priority, Shmyriority - 90 More Days to Prepare for Launch - Remain Positively Inclined
Go back to Needham & Company Reiterates a 'Buy' on Regeneron Pharma (REGN); Priority, Shmyriority - 90 More Days to Prepare for Launch - Remain Positively Inclined| Regeneron (NASDAQ: REGN) | Delayed: 803.48 -2.49 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $805.97 | 52 Week High | $592.36 | |||
| Open | $802.35 | 52 Week Low | $325.35 | |||
| Day High | $806.54 | P/E | 210.89 | |||
| Day Low | $792.57 | EPS | $3.81 | |||
| Volume | 425,599 | |||||

